NCT02285738.

Trial name or title	Anti‐platelet and statin therapy to prevent cancer‐associated thrombosis: a pilot study
Methods	Open‐label, parallel‐assignment RCT
Participants	Patients with a histologic diagnosis of malignancy of a solid organ or lymphoma who have a VTE risk score of 1 or higher and will be initiating a new systemic chemotherapy regimen
Interventions	Intervention 1: aspirin Intervention 2: simvastatin Control: observation
Outcomes	Primary outcome: change in average sP‐selectin levels Secondary outcomes: major bleeding complications or clinically significant non‐bleeding complications, change in circulating biomarkers, thrombotic events including venus thrombosis, pulmonary embolism, visceral vein thrombosis as well as arterial thromboembolic events including stroke, myocardial infarction, or arterial embolism
Starting date	December 2014
Contact information
Notes	ClinicalTrials.gov identifier: NCT02285738